At a glance
- Originator Abbott Laboratories
- Class Antiallergics; Antihypotensives
- Mechanism of Action Platelet activating factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Septic shock
Most Recent Events
- 10 Jul 1998 No-Development-Reported for Septic shock in USA (IV)
- 27 Jun 1995 Phase-I clinical trials for Septic shock in USA (IV)